Clinical Trial Update: Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an Internet-based compliance enhancement tool for people with hypercholesterolemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia | Phase 4 | Status: WITHDRAWN